New Step by Step Map For Elimusertib
HR001 was observed to possess an efficacious response for clients with relapsed/refractory non-Hodgkin lymphoma.Experimental: Dose expansion_sub-populace 2_higher dose of niraparib MTDs and/or applicant RP2Ds for elimusertib applied in combination with niraparib at a greater mounted dose.The many genes on the DDR panel are annotated with OncoKB, a